Hoitt Jason
SEC insider (Form 3/4/5 filer). CIK 0001762572. Chief Patient Officer at Stoke Therapeutics, Inc. (STOK). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 18, 2026. Located in BEDFORD, MA.
Companies Hoitt Jason has filed insider reports for
- Stoke Therapeutics, Inc. (STOK): Officer, Chief Patient Officer
Hoitt Jason
CIK: 0001762572
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Stoke Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect30 shares at avg. $32.85$985.5 - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect1.8K shares at avg. $31.28$55K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect139 shares at avg. $31.79$4K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect1K shares at avg. $32.74$34K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect748 shares at avg. $33.38$25K - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
ExerciseDirect10K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
72K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AwardDirectRestricted Stock Units
48K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 30 | $32.85 | $986 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 1,762 | $31.28 | $55,122 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 139 | $31.79 | $4,419 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 1,033 | $32.74 | $33,820 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 748 | $33.38 | $24,965 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise | 10,000 | - | $0 | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 72,000 | - | - | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award Restricted Stock Units | 48,000 | - | - | Direct |
1-8 of 8 transactions